Vascular Disease in Diabetes
- 1 February 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 139 (2) , 225-230
- https://doi.org/10.1001/archinte.1979.03630390077027
Abstract
Vascular disease is the major cause of morbidity and mortality in diabetes mellitus. Data from the recent comprehensive report from the National Commission on Diabetes suggested that diabetics are two times more prone to heart attacks, five times more prone to gangrene, 17 times more prone to kidney failure, and 25 times more prone to blindness than nondiabetics.1These sobering statistics reflect the ravages of accelerated atherosclerosis plus a relatively specific form of microvascular disease in multiple organ systems in the diabetic. Recent progress has been made in the understanding of the mechanisms involved both in large-vessel disease (macrovascular disease) and small-vessel disease (microvascular disease) in patients with diabetes mellitus. With an increased understanding of the mechanisms involved, intelligent decisions about therapy may be more easily made. We briefly review the current thoughts about the pathophysiologic features of diabetic vascular disease and make therapeutic recommendations based on these observations.This publication has 14 references indexed in Scilit:
- Autoimmunity in chronic active hepatitis and diabetes mellitusClinical Immunology and Immunopathology, 1977
- Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.Journal of Clinical Investigation, 1976
- Metabolism of [14C]arachidonic acid by human plateletsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells.Journal of Clinical Investigation, 1975
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975
- Prostaglandin Endoperoxides. A New Concept Concerning the Mode of Action and Release of ProstaglandinsProceedings of the National Academy of Sciences, 1974
- Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human PlateletsProceedings of the National Academy of Sciences, 1974
- Aspirin Selectively Inhibits Prostaglandin Production in Human PlateletsNature New Biology, 1971
- Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitusDiabetologia, 1970
- Platelet Aggregation in Diabetes MellitusPublished by S. Karger AG ,1970